Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0080178
Disease: Spina Bifida
Spina Bifida
0.330 Biomarker disease BEFREE Vangl2 disruption alters the biomechanics of late spinal neurulation leading to spina bifida in mouse embryos. 29590636 2018
CUI: C0080178
Disease: Spina Bifida
Spina Bifida
0.330 GeneticVariation disease BEFREE Overexpression of Grainyhead-like 3 causes spina bifida and interacts genetically with mutant alleles of Grhl2 and Vangl2 in mice. 30189017 2018
CUI: C0080178
Disease: Spina Bifida
Spina Bifida
0.330 Biomarker disease BEFREE Protein tyrosine kinase 7 (Ptk7) was shown to cause a very severe form of NTDs called craniorachischisis in a mouse model and genetically interacts with a core PCP member Vangl2 where double heterozygotes suffer from spina bifida. 26368655 2015
CUI: C0080178
Disease: Spina Bifida
Spina Bifida
0.330 Biomarker disease CTD_human A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene. 21404367 2011
CUI: C0038219
Disease: Status Dysraphicus
Status Dysraphicus
0.300 Biomarker disease CTD_human A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene. 21404367 2011
CUI: C0266508
Disease: Rachischisis
Rachischisis
0.300 Biomarker disease CTD_human A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene. 21404367 2011
Spina bifida aperta of cervical spine
0.300 SusceptibilityMutation disease ORPHANET Contribution of VANGL2 mutations to isolated neural tube defects. 20738329 2011
CUI: C0011999
Disease: Diastematomyelia
Diastematomyelia
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0027806
Disease: Neurenteric Cyst
Neurenteric Cyst
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0080218
Disease: Tethered Cord Syndrome
Tethered Cord Syndrome
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0152234
Disease: Iniencephaly
Iniencephaly
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0266453
Disease: Exencephaly
Exencephaly
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0344479
Disease: Spinal Cord Myelodysplasia
Spinal Cord Myelodysplasia
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C0702169
Disease: Acrania
Acrania
0.300 Biomarker disease CTD_human Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse. 2373757 1990
CUI: C1845026
Disease: Neural tube defects X-linked
Neural tube defects X-linked
0.200 Biomarker disease MGD Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. 9545534 1998
CUI: C1845027
Disease: Spina Bifida, X-Linked
Spina Bifida, X-Linked
0.200 Biomarker disease MGD Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. 9545534 1998
Neural tube defect, folate-sensitive
0.200 Biomarker disease MGD Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. 9545534 1998
CUI: C1866559
Disease: Spina Bifida, Folate-Sensitive
Spina Bifida, Folate-Sensitive
0.200 Biomarker disease MGD Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. 9545534 1998
CUI: C0025312
Disease: Meningomyelocele
Meningomyelocele
0.110 Biomarker disease BEFREE PCP rare putative mutations had a weaker role in myelomeningocele (SB), being found in approximately 6% of cases and cumulated across CELSR1, FUZ, FZD6, PRICKLE1, VANGL1, and VANGL2. 23024041 2012
CUI: C0025312
Disease: Meningomyelocele
Meningomyelocele
0.110 Biomarker disease HPO
CUI: C0005890
Disease: Body Height
Body Height
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0001403
Disease: Addison Disease
Addison Disease
0.100 Biomarker disease HPO
CUI: C0020255
Disease: Hydrocephalus
Hydrocephalus
0.100 Biomarker disease HPO
CUI: C0023798
Disease: Lipoma
Lipoma
0.100 Biomarker disease HPO
CUI: C0042024
Disease: Urinary Incontinence
Urinary Incontinence
0.100 Biomarker phenotype HPO